Skindex, a quality-of-life measure for patients with skin disease: Reliability, validity, and responsiveness

Journal of Investigative Dermatology

Volumn 107, Issue 5, 1996, Pages 707-713

  Chren, Mary Margaret ^a,b   Lasek, Rebecca J ^a   Quinn, Linda M ^a   Mostow, Eliot N ^a,b   Zyzanski, Stephen J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

Health status measure; Psychometric testing

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEAR; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; SKIN DISEASE; SKIN INFLAMMATION; SOCIAL PSYCHOLOGY;

EID: 0029827807     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12365600     Document Type: Article

References (49)

1. Aday LA: Designing and Conducting Health Surveys. A Comprehensive Guide, 1st ed. Jossey-Bass Publishers, San Francisco, 1989
2. American College of Physicians: Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med 117:1038-1041, 1992
3. Bergner M, Bobbitt RA, Carter WB, Gilson BS: The Sickness Impact Profile: development and final revision of a health status measure. Med Care 19:787-805, 1981
4. Bukowski C: Ham on Rye. Black Sparrow Press, Santa Rosa, CA, 1993
5. Comrey AL: Methodological contributions to clinical research. Factor-analytic methods of scale development in personality and clinical psychology. J Consult Clin Psychol 56:754-761, 1988
6. Cox J, Naylor CD: The Canadian Cardiovascular Society grading scale for angina pectoris: is it time for refinements? Ann Intern Med 117:677-683, 1992
7. Cronbach LJ: Coefficient alpha and the internal-structure of tests. Psychometrika 16:297-334, 1951
8. de Bruin AF, Diederiks JPM, de Witte LP, Stevens FCJ, Philipsen H: The development of a short generic version of the Sickness Impact Profile. J Clin Epidemilo 47:407-418, 1994
9. Dooley G, Finlay AY: Personal construct systems of psoriatic patients. Clin Exp Dermatol 15:401-405, 1990
10. Eddy DM: Connecting value and costs. Whom do we ask, and what do we ask them? JAMA 264:1737-1739, 1990
11. Epstein RS, Deverka PA, Chute CG, Panser L, Oesterling JE, Lieber MM, Schwartz S, Patrick D: Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol 45:1431-1445, 1992
12. Feinstein AR: Clinimetrics. Yale University Press, New Haven, CT. 1987
13. Finlay AY, Kelly SE: Psoriasis-an index of disability. Clin Exp Dermatol 12:8-11, 1987
14. Finlay AY, Khan GK: Dermatology life quality index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 19:210-216, 1994
15. Finlay AY, Khan GK, Luscnmbe DK, Salek MS: Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis. Br J Dermatol 123:751-756, 1990
16. Gill TM, Feinstein AR: A critical appraisal of the quality of quality-of-life measurements. JAMA 272:619-626, 1994
17. Gorsuch RL: Factor Analysis, W.B. Saunders Co. Philadelphia, 1974
18. Guyatt GH, Deyo RA, Charlson M, Levine MN, Mitchell A: Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol 42:403-408, 1989
19. Guyatt GH, Kirshner B, Jaeschke R: Measuring health status: what are the necessary measurement properties? J Clin Epidemiol 45:1341-1345, 1992
20. Hlatky MA: Patient preferences and clinical guidelines. JAMA 273:1219-1220, 1995
21. Jowett S, Ryan T: Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 20:425-429, 1985
22. Kaplan RM, Bush JW, Berry CC: Health status: types of validity and the index of well-being. Health Serv Res 11:478-507, 1976
23. Kent G, Al-Abadie M: The psoriasis disability index-further analyses. Clin Exp Dermatol 18:414-416, 1993
24. Kirshner B, Guyatt G: A methodological framework for assessing health indices. J Chron Dis 38:27-36, 1985
25. Lindholm C, Bjellerup M, Christensen OB, Zederfeldt B: Quality of life in chronic leg ulcer patients. An assessment according to the Nottingham Health Profile. Acta Derm Venereol (Stockh) 73:440-443, 1993
26. Lubeck DP, Patrick DL, McNulty P, Fifer SK, Birnbaum J: Quality of life of persons with onychomycosis. Qual Life Res 2:341-348, 1993
27. McHenry PM, Doherty VR: Psoriasis: an audit of patients' views on the disease and its treatment. Br J Dermatol 127:13-17, 1992
28. McHorney CA, Ware JE, Raczek AE: The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:247-263, 1993
29. McNeil BJ, Weichselbaum R, Pauker SG: Fallacy of the five-year survival in lung cancer. N Engl J Med 299:1397-1401, 1978
30. Medansky RS, Handler RM, Medansky DL: Self-evaluation of acne and emotion: a pilot study. Psychosomatics 22:379-383, 1981
31. Motley RJ, Finlay AY: How much disability is caused by acne? Clin Exp Dermatol 14:194-198, 1989
32. Motley RJ, Finlay AY: Practical use of a disability index in the routine management of acne. Clin Exp Dermatol 17:1-3, 1992
33. Nadelson T: A person's boundaries: a meaning of skin disease. Cutis 21:90-94, 1978
34. Nease RF, Jr., Kneeland T, O'Connor GT, Sumner W, Lumpkins C, Shaw L, Pryor D, Sox HC: Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. JAMA 273: 1185-1190, 1995
35. Nunnally JC: Psychometric Theory, 2nd ed. McGraw-Hill, New York, 1978
36. O'Connor AMC, Boyd NF, Warde P, Stolbach L, Till JE: Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences. J Chron Dis 40:811-818, 1987
37. Porter JR, Beuf AH: Racial variation in reaction to physical stigma: a study of degree of disturbance by vitiligo among black and white patients. J Health Soc Behav 32:192-204, 1991
38. Read JL, Quinn RJ, Hoefer MA: Measuring overall health: an evaluation of three important approaches. J Chron Dis 40:7S-21S, 1987
39. Salek MS, Finlay AY, Luscombe DK, Allen BR, Berth-Jones J, Camp RDR, Graham-Brown RAC, Khan GK, Marks R, Motley RJ, Ross JS, Sowden JM: Cydosporin greatly improves the quality of life of adults with severe a topic dermatitis. A randomized, double-blind, placebo-controlled trial. Br J Dermatol 129:422-430, 1993
40. Savin JA: Patients' beliefs about psoriasis. Transactions of the St. Johns Hospital Dermatologcal Society 56:139-142, 1970
41. Shuster S, Fisher GH, Harris E, Binnell D: The effect of skin disease on self image. Br J Dermatol 99:18-19, 1978
42. Sonino N, Fava GA, Mani E, Belluardo P, Boscaro M: Quality of life in hirsute women. Postgrad Med J 69:186-189, 1993
43. Testa MA, Simonson DC: Assessment of quality-of-life outcomes. N Engl J Med 334:835-840, 1996
44. Updike J: From the journal of a leper. The New Yorker 52:28-33, 1976
45. Updike J: Personal History. At war with my skin. The New Yorker 61:39-57, 1985
46. Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36): I, Conceptual framework and item selection. Med Care 30:473-483, 1992
47. Wessely SC, Lewis GH: The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 155:686-691, 1989
48. Whitlock FA: Psychophysiological aspects of skin disease. In: Rook A (ed.) Major Problems in Dermatology. W.B. Saunders Compan, Ltd., London, 1976, pp. 58-68
49. Wilson IB, Cleary/ PD: Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 273:59-65, 1995